These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6276727)

  • 1. Clinical studies on the role of endorphins in schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Mod Probl Pharmacopsychiatry; 1981; 17():226-35. PubMed ID: 6276727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endomorphines in schizophrenia].
    Gilbert JL
    Biomed Pharmacother; 1987; 41(1):36-40. PubMed ID: 3038207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of opioid receptor antagonists in psychopathologic states.
    Janowsky DS; Judd LL; Huey LY; Risch SC; Segal DS
    Psychiatr Clin North Am; 1983 Sep; 6(3):403-14. PubMed ID: 6316300
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigating opioid peptides in schizophrenia and depression.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 9. Endorphins in schizophrenia.
    van Ree JM; De Wied D
    Neuropharmacology; 1981 Dec; 20(12B):1271-7. PubMed ID: 6172743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endorphins and their significance for psychopathology].
    van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1979 Mar; 123(9):327-34. PubMed ID: 216935
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist.
    Naber D; Münch U; Wissmann J; Grosse R; Ritt R; Welter D
    Acta Psychiatr Scand; 1983 Apr; 67(4):265-71. PubMed ID: 6305111
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-Endorphin administration to acute schizophrenic patients: a double blind study.
    Pethö B; Gráf L; Karczag I; Borvendég J; Bitter I; Barna I; Hermann I; Tolna J; Baraczka K
    Ann N Y Acad Sci; 1982; 398():460-9. PubMed ID: 6297365
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of beta-endorphin in depression and schizophrenia.
    Catlin DH; Gorelick DA; Gerner RH
    Ann N Y Acad Sci; 1982; 398():434-47. PubMed ID: 6297363
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous opiates and schizophrenia: directions in clinical research.
    Goldbloom DS
    Can J Psychiatry; 1984 Jun; 29(4):355-60. PubMed ID: 6145518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of beta-endorphin in psychiatric patients.
    Berger PA; Barchas JD
    Ann N Y Acad Sci; 1982; 398():448-59. PubMed ID: 6297364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endogenous opioids and gamma type endorphins in schizophrenia].
    Verhoeven WM
    Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
    Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
    Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between gamma-type endorphins and HLA class I antigens.
    Claas FH; van Ree JM; Verhoeven WM; van der Poel JJ; Verduyn W; de Wied D; van Rood JJ
    Hum Immunol; 1986 Apr; 15(4):347-56. PubMed ID: 2422143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.